정신과 의사와 비정신과 의사의 항우울제 처방에 대한 연구 : 건강보험심사평가원 청구 데이터 중심으로
The Epidemiology of Antidepressant Prescriptions in South Korea from the Viewpoint of Medical Providers : A Nationwide Register-Based Study
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Antidepressants are widely used to treat depression in Korea, however, only a few studies have focused on the provider of the treatment. The aim of the study is to compare the differences between patients who were prescribed antidepressants by psychiatrists and those who were prescribed antidepressants by non-psychiatrists in South Korea. Patients with a diagnosis of depressive disorder who had been newly prescribed antidepressants in 2012 were selected from the Health Insurance Review and Assessment Service database. They were classified into two groups depending on whether they received the antidepressant prescription from a psychiatrist or non-psychiatrist. Sociodemographic, clinical, and depression related cost has been investigated. Treatment resistant depression, which is defined as a failure of two antidepressant regimens to alleviate symptoms, was also investigated. Prescription adequacy was assessed based on whether a regimen was maintained for at least 4 weeks. Among the 834694 patients with pharmaceutically treated depression (PTD) examined in this study, 326122 (39.1%) were treated by psychiatrists. Patients who were treated by psychiatrists were younger and had more psychiatric comorbidities than those treated by non-psychiatrists. They had longer PTD duration (229.3 days vs. 103.0 days, p < 0.05) and a larger proportion of treatment resistant depression (9.3% of PTD) when compared to those patients treated by non-psychiatrists. The patients treated by psychiatrists had a smaller proportion of inadequate antidepressant use compared to those patients in the non-psychiatrist group (44.5% vs. 65.1%, p < 0.05). The costs related to depression corrected with PTD duration were higher in the nonpsychiatrist group (32214 won vs. 56001 won, p < 0.05). Patients who receive antidepressants from psychiatrists are patients with more severe, treatment-resistant depression. Psychiatrists prescribe antidepressants more adequately and cost- effectively than non-psychiatrists.
Abstract
Antidepressants are widely used to treat depression in Korea, however, only a few studies have focused on the provider of the treatment. The aim of the study is to compare the differences between patients who were prescribed antidepressants by psychiatrists and those who were prescribed antidepressants by non-psychiatrists in South Korea. Patients with a diagnosis of depressive disorder who had been newly prescribed antidepressants in 2012 were selected from the Health Insurance Review and Assessment Service database. They were classified into two groups depending on whether they received the antidepressant prescription from a psychiatrist or non-psychiatrist. Sociodemographic, clinical, and depression related cost has been investigated. Treatment resistant depression, which is defined as a failure of two antidepressant regimens to alleviate symptoms, was also investigated. Prescription adequacy was assessed based on whether a regimen was maintained for at least 4 weeks. Among the 834694 patients with pharmaceutically treated depression (PTD) examined in this study, 326122 (39.1%) were treated by psychiatrists. Patients who were treated by psychiatrists were younger and had more psychiatric comorbidities than those treated by non-psychiatrists. They had longer PTD duration (229.3 days vs. 103.0 days, p < 0.05) and a larger proportion of treatment resistant depression (9.3% of PTD) when compared to those patients treated by non-psychiatrists. The patients treated by psychiatrists had a smaller proportion of inadequate antidepressant use compared to those patients in the non-psychiatrist group (44.5% vs. 65.1%, p < 0.05). The costs related to depression corrected with PTD duration were higher in the nonpsychiatrist group (32214 won vs. 56001 won, p < 0.05). Patients who receive antidepressants from psychiatrists are patients with more severe, treatment-resistant depression. Psychiatrists prescribe antidepressants more adequately and cost- effectively than non-psychiatrists.
참고문헌 (35)
- Murray CJ, "Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study", Lancet, 349, pp.1436~1442 (1997)
- Berto P, "Depression:cost-of-illness studies in the international literature, a review", J Ment Health Policy Econ, 3, pp.3~10 (2000)
- Greenberg PE, "The economic burden of adults with major depressive disorder in the United States(2005 and 2010)", J Clin Psychiatry, 76, pp.155~162 (2015)
- Paulose-Ram R, "Trends in psychotropic medication use among U.S. adults", Pharmacoepidemiol Drug Saf, 16, pp.560~570 (2007)
- Alonso J, "Psychotropic drug utilization in Europe : results from the European Study of the Epidemiology of Mental Disorders(ESEMeD)project", Acta Psychiatr Scand Suppl, 109, pp.55~64 (2004)
- Wang PS, "Twelve-month use of mental health services in the United States : results from the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.629~640 (2005)
- Henriksson S, "Infrequent use of antidepressants in depressed individuals(an interview and prescription database study in a defined Swedish population 2001-2002)", Eur Psychiatry, 21, pp.355~360 (2006)
- Goldberg DP, "Common Mental Disorders: A Bio-Social Model" (1992), Routledge
- Sireling LI, "Depression in general practice : clinical features and comparison with out-patients", Br J Psychiatry, 147, pp.119~126 (1985)
- Sireling LI, "Depression in general practice : case thresholds and diagnosis", Br J Psychiatry, 147, pp.113~119 (1985)
- Simon GE, "Treatment process and outcomes for managed care patients receiving new antidepressant prescriptions from psychiatrists and primary care physicians", Arch Gen Psychiatry, 58, pp.395~401 (2001)
- Vuorilehto MS, "Do characteristics of patients with major depressive disorder differ between primary and psychiatric care?", Psychol Med, 37, pp.893~904 (2007)
- McManus P, "Use of antidepressants by general practitioners and psychiatrists in Australia", Aust N Z J Psychiatry, 37, pp.184~189 (2003)
- Kerr MP, "Antidepressant prescribing : a comparison between general practitioners and psychiatrists", Br J Gen Pract, 44, pp.275~276 (1994)
- Sihvo S, "Antidepressant utilisation patterns and determinants of shortterm and non-psychiatric use in the Finnish general adult population", J Affect Disord, 110, pp.94~105 (2008)
- Lawrence RE, "Primary care physicians’ and psychiatrists’ approaches to treating mild depression", Acta Psychiatr Scand, 126, pp.385~392 (2012)
- Kniesner TJ, "Provider type and depression treatment adequacy", Health Policy, 72, pp.321~332 (2005)
- Sturm R, "How can care for depression become more costeffective?", JAMA, 273, pp.51~58 (1995)
- Croghan TW, "Effect of mental health specialty care on antidepressant length of therapy", Med Care, 37, pp.AS20~AS23 (1999)
- 박기동, "일차 의료 강화를 위한 의료체계 및 건강보험체계 개선 방향: 한국, 일본, 대만의 비교 분석", Korean Journal of Family Medicine, 24(4), pp.4~345 (2003), 대한가정의학회
- "Practice Guidelines for the Treatment of Patients with Major Depressive Disorder" (2010)[URL]
- Desseilles M, "Assessing the adequacy of past antidepressant trials : a clinician’s guide to the antidepressant treatment response questionnaire", J Clin Psychiatry, 72, pp.1152~1154 (2011)
- Fife D, "Epidemiology of pharmaceutically treated depression and treatment resistant depression in Taiwan", Psychiatry Res, 252, pp.277~283 (2017)
- Davidson JR, "Atypical depression", Arch Gen Psychiatry, 39, pp.527~534 (1982)
- Birmaher B, "Childhood and adolescent depression: a review of the past 10 years. Part I", J Am Acad Child Adolesc Psychiatry, 35, pp.1427~1439 (1996)
- Kessler RC, "Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication", Arch Gen Psychiatry, 62, pp.617~627 (2005)
- Melartin TK, "Severity and comorbidity predict episode duration and recurrence of DSM-IV major depressive disorder", J Clin Psychiatry, 65, pp.810~819 (2004)
- Hirschfeld RM, "The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression", JAMA, 277, pp.333~340 (1997)
- Davidson JR, "The underrecognition and undertreatment of depression : what is the breadth and depth of the problem?", J Clin Psychiatry, 60, pp.4~9 (1999)
- Weilburg JB, "Evaluation of the adequacy of outpatient antidepressant treatment", Psychiatr Serv, 54, pp.1233~1239 (2003)
- Tarricone R, "Metodologia di indagine e primi risultati sul costo sociale della depressione maggiore in Italia", Mecosan, 6, pp.57~68 (1997)
- Demyttenaere K, "Risk factors and predictors of compliance in depression", Eur Neuropsychopharmacol, 13, pp.69~75 (2003)
- Demyttenaere K, "Compliance during treatment with antidepressants", J Affect Disord, 43, pp.27~39 (1997)
- Maddox JC, "The compliance with antidepressants in general practice", J Psychopharmacol, 8, pp.48~52 (1994)
- Tai-Seale M, "Determinants of antidepressant treatment compliance : implications for policy", Med Care Res Rev, 57, pp.491~512 (2000)